<pad> Vaccine-HPV 11 917 1,305 (1,225–1,390) 99.9 3,353 749 (726–773) 99.8Anti-HPV 16 915 4,919 (4,557–5,309) 99.9 3,249 2,409 females (2,309–2,514) 99.8Anti-HPV 18 922 1,043 (968–1,123) 99.8 3,566 475 (459–492) 99.4Assay (cLIA)Males aged 9–15 years Males aged 16–26 yearsNo. GMT (mMU/mL) (95% CI) Seropositivity %Anti-HPV 6 884 1,038 (963–1,117) 99.9 1,093 448 (419–479) 98.9Anti-HPV 11 885 1,387 (1,298–1,481) 99.9 1,093 624 (588–662) 99.2Anti-HPV 16 882 6,056 (5,601–6,549) 99.8 1,136 2,403 (2,243–2,575) 98.8Anti-HPV 18 887 1,357 (1,249–1,475) 99.8 1,175 403 (375–433) 97.4Abbreviations: CI = confidence interval; cLIA =</s>